Sienna Biopharmaceuticals, Inc.
Country not established
- Devices
- 1
What Sienna Biopharmaceuticals, Inc. makes
Sienna Biopharmaceuticals, Inc. manufactures the SNA-001 Silver Photoparticle Topical Gel, a photodynamic therapy agent designed for topical skin applications.
The company’s portfolio is regulated under FDA’s Class II device classification, with the SNA-001 Silver Photoparticle Topical Gel listed via a 510(k) submission. The company is based in the United States.
Catalogue
SNA-001 Silver Photoparticle Topical Gel Ref K192620
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Sienna Biopharmaceuticals, Inc. have in the registry?
The registry currently lists 1 device for Sienna Biopharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Sienna Biopharmaceuticals, Inc.'s devices?
Among its 1 most recently registered device, Sienna Biopharmaceuticals, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Sienna Biopharmaceuticals, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Sienna Biopharmaceuticals, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Sienna Biopharmaceuticals, Inc. in the registry?
The most recently registered devices listed for Sienna Biopharmaceuticals, Inc. include SNA-001 Silver Photoparticle Topical Gel.